Skip to content
Back to Investors
AC

Anglia Capital Group

Venture Capital

Anglia Capital Group is an angel investment network that backs early-stage and growth businesses providing innovative solutions.

Portfolio

19

companies

Investment by month

By category

  • FoodTech£5.9M
  • CleanTech£4.6M
  • BioTech£1.3M
  • MarTech£825K
  • AgriTech£750K
  • Other£2.6M

By location

  • Norwich£8.3M
  • Suffolk£4.8M
  • Bury St Edmunds£1.4M
  • Essex£825K
  • United Kingdom£420K
  • Other£175K

Portfolio companies

AT

Ablatus Therapeutics

Ablatus Therapeutics develops advanced medical technology for treating tumours.

A

AgriSound

AgriSound creates acoustic sensors to monitor insect activity and protect pollinator populations.

B

Beep

Beep provides digital campus cards for university students.

C

Cellexcel

Cellexcel develops technology to enhance the water resistance of plant-based biomaterials.

C

Crossip

Crossip produces a distinct range of botanical non-alcoholic spirits.

DE

Developing Experts

Developing Experts builds digital educational software for classroom teachers.

View all 19 companies

Team

HS

Hannah Smith

Managing Director

SM

Struan McDougall

CEO

HW

Helen Withers

Member and Investor

LH

Laura Hood

Operations Director

Laura is Director of Operations at Anglia Capital Group, having previously served as Business Development Manager and Marketing Manager within the same organisation. Her earlier career includes marketing roles at IJYI and CLTRe.

LinkedIn
HB

Hannah Brynn

Managing Director

Hannah brings investment and commercialisation experience from roles at Anglia Capital Group and Teesside University. She previously held investment positions with Cambridge Capital Group and New Anglia Local Enterprise Partnership.

LinkedIn

Recent investments

Pre-Seed
£420K

The oversubscribed round drew backing from private investors alongside Sheffield Angels, Anglia Capital Group and FundmyPitch.

"Humanity has never documented so much of its life, yet never felt so disconnected from its memories. We are entering an era where memory is not just data — it is identity, wellbeing and legacy. Memorify exists to help people reconnect with the moments that matter and enable the multigenerational secure storage of those memories. What struck me wasn’t the absence of memories, it was the absence of structure. The moments existed across devices and platforms, but there was no intelligent system designed to bring them together into a meaningful story. That’s when I realised this wasn’t just my problem, it was a global one."
— Charlotte Ridley, CEO and Founder
Seed
£100K

Anglia Capital Group backs Norwich-based Virilitas Labs with a £100k investment.

"The founders demonstrated a strong grasp of the clinical and commercial needs in this space. Their technology addresses an important issue that resonates strongly with our investors, who are committed to backing impactful innovation. We’re thrilled to welcome Virilitas Labs into the ACG portfolio and support their next stage of growth."
— Laura Hood, Operations Director
£1.4M

The bottled cocktail producer has secured capital to scale its operations and expand its market reach.

"Tom and Paul delivered an excellent pitch with a clear route to market and unique positioning. The ACG team were delighted to be able to present this brilliant company to the membership and we’re excited to them to scale and grow"
— Hannah Brynn, Managing Director
£4.0M

The Suffolk drinks producer has raised capital to scale its non-alcoholic spirits business.

"Anglia Capital Group is excited to invest in Crossip, a company that is reshaping the landscape of non-alcoholic spirits. Crossip have shown a dedication to quality and innovation and we’re excited to be part of their journey."
— Hannah Smith, Managing Director